"We are very excited by the data thus far and think this approach could provide real benefit for patients in the future" added Dr. Matthew Baker MD Clinical Chief, Division of Immunology and Rheumatology, Stanford University and an advisor to Nēsos. "The overwhelmingly positive feedback we have received from patients has been great to see. We look forward to taking the next steps in further understanding the potential this device has to offer. "...
Nēsos aims to transform disease treatment by developing brain interfaces that help the brain regain control of immune function.